WASHINGTON - U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer.
That pill is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.As a result, Merck's pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago.
Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.The Food and Drug.